A detailed history of True Wealth Design, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, True Wealth Design, LLC holds 267 shares of ADPT stock, worth $3,764. This represents 0.0% of its overall portfolio holdings.

Number of Shares
267
Previous 241 10.79%
Holding current value
$3,764
Previous $2.81 Million 42.27%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 21, 2025

BUY
$10.24 - $14.96 $266 - $388
26 Added 10.79%
267 $4 Million
Q2 2025

Aug 06, 2025

SELL
$6.83 - $12.16 $20 - $36
-3 Reduced 1.23%
241 $2.81 Million
Q1 2025

May 13, 2025

BUY
$6.07 - $8.66 $297 - $424
49 Added 25.13%
244 $1.81 Million
Q3 2024

Nov 14, 2024

BUY
$3.37 - $5.12 $657 - $998
195 New
195 $999,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $2.01B
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track True Wealth Design, LLC Portfolio

Follow True Wealth Design, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Wealth Design, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Wealth Design, LLC with notifications on news.